EUCODIS Bioscience delivers high-performance enzyme solutions for highly specific applications in biopharma, fine chemicals, cosmetics industry and others.
With a portfolio of over 50 enzymes including innovative lipases, beta-lactamases, peroxidases and other enzymes EUCODIS Bioscience has a proven track record of providing customized enzyme solutions.
EUCODIS Bioscience provides customized services in recombinant protein and enzyme production by covering the whole spectrum of bioprocess development up to industrial-scale manufacture of your target proteins under ISO9001.
Eucodis, an established Austrian enzyme engineering and manufacturing company, developed and patented a catalase as a novel neutralizer in environmental monitoring media and offers either a collaboration or OEM supply of the enzyme or the technology itself for licensing.
Eucodis’ patented recombinant catalase formulation is unique as it is the only one worldwide that can be applied to agar plates due to its increased stability at high temperatures (stable at 55°C during production and during sterilization by gamma-irradiation).
Within the ChitoTex project EUCODIS Bioscience, the Fraunhofer IGB and Norwegian University of Life Sciences (NMBU) collaborated to establish a new enzyme based approach to produce chitosan for the treatment of textile fibers and yarns in a more sustainable way. EUCODIS played an important role in the screening and modification of those enzymes aiming to develop suitable expression systems as well as efficient, stable, recombinant enzymes to produce chitosan.
- EUCODIS Bioscience developed enzyme and enzymatic production method for PrEP Biopharm drug intermediate
- Eucodis starts commercialization of tubulysin A and B
- ProBioGen AG and EUCODIS Bioscience sign agreement to commercialize C-LiNK, A novel antibody drug conjugation technology
- Antibody Drug Conjugate Using CTAT Linker Technology Shows Superior Efficacy in Xenograft Trial